Helen Reynolds

5PUBLICATIONS
41CO-AUTHORS
Medical virologyPharmaceutical delivery technologiesPsychosocial aspects of childbirth and perinatal mental healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

|Mar 04, 2026
Infant HIV transmission despite maternal viral suppression: a case of post-weaning seroconversion.

Shadia Nakalema, Diana Namuddu, Isabella Kyohairwe

|Oct 26, 2021
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.

Lauren E Walker, Richard FitzGerald, Geoffrey Saunders

|Sep 21, 2019
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).

Catriona Waitt, Catherine Orrell, Stephen Walimbwa

Pageof 1

Frequent Collaborators

4 joint publications

Saye Khoo

3 joint publications

Andrew Owen

2 joint publications

Richard FitzGerald

2 joint publications

Justin Chiong